Centers for Disease Control and Prevention (CDC) — 2021 Investments
7 investments dated 2021 · listed companies and verified rows first · show all
AI Biosciences develops the µTitan, an automated, microgravity-compatible Sample Processing Instrument that handles six samples per roughly 20-minute run.
BiotechHealthtechMedical Devices
Seattle, US
Virginia Emery(Executive Officer, Director, Promoter)
Charles River Analytics develops advanced AI, autonomy, and robotics systems—spanning sensor fusion, perception, and human-robot interaction—for applications including defense, homeland security threat detection, healthcare, and worker safety.
AI & Machine LearningDefense TechRobotics
Antigen Discovery Inc.
BiotechDeep Tech
PAI Life Sciences is a biotechnology company conducting developmental and translational research to develop protein biotherapeutics, vaccines, and adjuvants, with a pipeline addressing neglected tropical diseases such as schistosomiasis, lymphatic filariasis, tuberculosis, and onchocerciasis, as well as cancer therapeutics.
BiotechHealthtechSeattle, US
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.